Adiponectin and adiponectin receptor in relation to colorectal cancer progression

Although obesity is a risk factor for colorectal cancer, the underlying mechanism is not clear. Adiponectin is an adipokine that binds to 2 types of receptors, AdipoR1 and AdipoR2. The plasma concentrations of adiponectin are reduced in obese individuals and adiponectin has been reported to have anticarcinogenic properties. Furthermore, AdipoR1 and AdipoR2 have been reported to be expressed in several malignancies. However, little is known about the expression of AdipoR1 and AdipoR2 in colorectal cancer and its clinicopathological implications. In addition, the relationship between adiponectin and colorectal cancer has not yet been determined. Here, we sought to investigate adiponectin and adiponectin receptors in relation to colorectal cancer. AdipoR1 and AdipoR2 immunostaining was detected in 72 and 68% of human colorectal cancer tissue, respectively. AdipoR1 and AdipoR2 expression levels were inversely related to T stage. The lowest AdipoR1 and AdipoR2 expression were detected in poorly differentiated adenocarcinoma. RT‐PCR also showed the expression of AdipoR1 and AdipoR2 in HCT116 and SW620. MTT assay and TUNEL assay demonstrated the tendency of growth inhibition and apoptosis induction in both cell lines after full‐length adiponectin treatment although statistically insignificant. Microarray analysis revealed several gene responses to full‐length adiponectin, including upregulation of ENDOGL1 and MT1G. In conclusion, AdipoR1 and AdipoR2 may be intimately related to the progression of colorectal cancer. Further studies may be warranted to assess adiponectin and its receptors as a novel target for inhibition of colorectal cancer growth.

[1]  E. Kubista,et al.  Impact of AdipoR1 expression on breast cancer development. , 2010, Gynecologic oncology.

[2]  J. Chen,et al.  Adiponectin and signal pathways in obesity-induced colon cancer. , 2009, Gut.

[3]  V. Barresi,et al.  The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma , 2009, Journal of Clinical Pathology.

[4]  Hirokazu Takahashi,et al.  Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. , 2009, International journal of oncology.

[5]  C. Mantzoros,et al.  Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study , 2009, Cancer Causes & Control.

[6]  H. Nakagama,et al.  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition , 2008, Gut.

[7]  J. Fenton,et al.  Adiponectin blocks multiple signaling cascades associated with leptin‐induced cell proliferation in ApcMin/+ colon epithelial cells , 2008, International journal of cancer.

[8]  Manuela Gariboldi,et al.  Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma , 2008, Laboratory Investigation.

[9]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[10]  Kwi-Sook Choi,et al.  Visceral obesity as a risk factor for colorectal neoplasm , 2008, Journal of gastroenterology and hepatology.

[11]  C. Mantzoros,et al.  Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. , 2008, Endocrine-related cancer.

[12]  M. Fukayama,et al.  Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue , 1994 .

[13]  C. Mantzoros,et al.  Circulating Adiponectin Levels and Expression of Adiponectin Receptors in Relation to Lung Cancer: Two Case-Control Studies , 2008, Oncology.

[14]  J. Arthur,et al.  Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[15]  C. Mantzoros,et al.  Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. , 2007, The American journal of clinical nutrition.

[16]  C. Vinson,et al.  The obesity-cancer link: lessons learned from a fatless mouse. , 2007, Cancer research.

[17]  C. Mantzoros,et al.  Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[18]  W. Willett,et al.  Plasma adiponectin concentrations and risk of incident breast cancer. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  C. Friedenreich,et al.  Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[20]  M. Dieudonné,et al.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[21]  D. English,et al.  Body size and composition and colon cancer risk in women , 2006, International journal of cancer.

[22]  M. Gunter,et al.  Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. , 2006, The Journal of nutritional biochemistry.

[23]  J. Bub,et al.  Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.

[24]  M. Chiriva-Internati,et al.  Influence of obesity on the risk of developing colon cancer , 2005, Gut.

[25]  B. Yu,et al.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell , 2005, Archives of pharmacal research.

[26]  W. Leung,et al.  Increasing incidence of colorectal cancer in Asia: implications for screening. , 2005, The Lancet. Oncology.

[27]  R. Hayes,et al.  Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. , 2005, Gastroenterology.

[28]  N. Cook,et al.  Body Mass Index and Risk of Colorectal Cancer in Women (United States) , 2004, Cancer Causes & Control.

[29]  M. Singer,et al.  BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults , 2004, International Journal of Obesity.

[30]  H. Yatsuya,et al.  A prospective study of body size and colon cancer mortality in Japan: The JACC Study , 2004, International Journal of Obesity.

[31]  D. English,et al.  Body size and composition and colon cancer risk in men. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  C. Mantzoros,et al.  Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Jayasurya,et al.  Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.

[35]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[36]  S. Deventer,et al.  Leptin is a growth factor for colonic epithelial cells. , 2001, Gastroenterology.

[37]  S. Sikka,et al.  In vivo gene expression profile analysis of metallothionein in renal cell carcinoma. , 2000, Cancer letters.

[38]  M. Thun,et al.  Body mass index and colon cancer mortality in a large prospective study. , 2000, American journal of epidemiology.

[39]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[40]  S. Garrett,et al.  Metallothionein isoform 1 and 2 gene expression in the human prostate: Downregulation of MT‐1X in advanced prostate cancer , 2000, The Prostate.

[41]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[42]  C. la Vecchia,et al.  Body size and colorectal‐cancer risk , 1998, International journal of cancer.

[43]  M. Slattery,et al.  Body size and the risk of colon cancer in a large case-control study , 1998, International Journal of Obesity.

[44]  L. Kolonel,et al.  Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. , 1997, Cancer research.

[45]  M. Rocchi,et al.  Chromosomal localization of mitochondrial transcription factor A (TCF6), single-stranded DNA-binding protein (SSBP), and endonuclease G (ENDOG), three human housekeeping genes involved in mitochondrial biogenesis. , 1995, Genomics.

[46]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.